Extrawell Pharmaceutical Holdings Limited (HKG:0858)
Hong Kong · Delayed Price · Currency is HKD 0.0780
-0.0020 (-2.50%)
Aug 27, 2026, 3:44 PM HKT
HKG:0858 Cash Flow Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -979.71 | 222.64 | -162.95 | 129.27 | 130.59 |
Depreciation & Amortization | 8.08 | 8.28 | 9.05 | 8.8 | 8.73 |
Loss (Gain) From Sale of Assets | -0.11 | -0.01 | - | - | 0.06 |
Loss (Gain) From Sale of Investments | 813.59 | -254.9 | 132.93 | -158.66 | -168.64 |
Loss (Gain) on Equity Investments | 3.43 | 2.31 | 2.28 | 3.85 | 3.65 |
Stock-Based Compensation | 1.22 | - | - | - | - |
Provision & Write-off of Bad Debts | -0.2 | -0.85 | 0.09 | 0.8 | -0.27 |
Other Operating Activities | 133.05 | 21.15 | 18.07 | 13.74 | 19.59 |
Change in Accounts Receivable | 1.35 | -2.8 | 1.37 | 1 | 3.19 |
Change in Inventory | 0.42 | 2.2 | -4.13 | 4.89 | -0.63 |
Change in Accounts Payable | -0.72 | -0.18 | -1.83 | 0.18 | -0.24 |
Change in Other Net Operating Assets | -0.63 | -3.38 | -2.97 | -3.53 | -0.14 |
Operating Cash Flow | 0.34 | -4.37 | -3.69 | 1.18 | -1.77 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -1.04 | -3.07 | -1.2 | -6.62 | -9.63 |
Sale of Property, Plant & Equipment | 0.11 | 0.01 | - | - | - |
Investment in Securities | 0.11 | -10.77 | - | -5.88 | - |
Other Investing Activities | 1.91 | 4.45 | 3.24 | 4.06 | 0.25 |
Investing Cash Flow | 1.09 | -9.38 | 2.04 | -8.44 | -9.38 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Repaid | -1.93 | -1.38 | -1.32 | -2.3 | -1.8 |
Net Debt Issued (Repaid) | -1.93 | -1.38 | -1.32 | -2.3 | -1.8 |
Issuance of Common Stock | 15.42 | - | - | - | - |
Other Financing Activities | -5.12 | -0.19 | -5.18 | -0.09 | -0.14 |
Financing Cash Flow | 8.37 | -1.58 | -6.5 | -2.39 | -1.94 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Foreign Exchange Rate Adjustments | 1.94 | -0.51 | -0.64 | 0.16 | -1.75 |
Net Cash Flow | 11.73 | -15.84 | -8.79 | -9.48 | -14.83 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -0.71 | -7.44 | -4.89 | -5.44 | -11.39 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -1.37% | -13.42% | -8.28% | -7.49% | -15.41% |
Free Cash Flow Per Share | - | -0.00 | -0.00 | -0.00 | -0.00 |
Levered Free Cash Flow | -0.86 | -2.4 | -23.07 | -14.71 | -9.53 |
Unlevered Free Cash Flow | 15.47 | 11.41 | -11.32 | -4.94 | -1.26 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 0.12 | 0.19 | 0.29 | 0.09 | 0.14 |
Cash Income Tax Paid | 0.06 | 0.04 | 0.07 | 0.38 | 0.06 |
Change in Working Capital | 0.42 | -4.16 | -6.48 | 2.54 | 2.18 |